Poor postnatal growth after preterm birth does not match the normal rapid growth in utero and is associated with preterm morbidities. Insulin-like growth factor 1 (IGF-1) axis is the major hormonal mediator of growth in utero, and levels of IGF-1 are often very low after preterm birth. We reviewed the role of IGF-1 in foetal development and the corresponding preterm perinatal period to highlight the potential clinical importance of IGF-1 deficiency in preterm morbidities. Conclusion There is a rationale for clinical trials to evaluate the potential benefits of IGF-1 replacement in very preterm infants.
Insulin-like growth factor 1 has multisystem effects on foetal and preterm infant development
Ramenghi L. A.;
2016-01-01
Abstract
Poor postnatal growth after preterm birth does not match the normal rapid growth in utero and is associated with preterm morbidities. Insulin-like growth factor 1 (IGF-1) axis is the major hormonal mediator of growth in utero, and levels of IGF-1 are often very low after preterm birth. We reviewed the role of IGF-1 in foetal development and the corresponding preterm perinatal period to highlight the potential clinical importance of IGF-1 deficiency in preterm morbidities. Conclusion There is a rationale for clinical trials to evaluate the potential benefits of IGF-1 replacement in very preterm infants.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
92 Insulin-like growth factor 1 has multisystem effects on foetal and preterm.pdf
accesso chiuso
Tipologia:
Documento in versione editoriale
Dimensione
712.94 kB
Formato
Adobe PDF
|
712.94 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.